Buy Dishman Pharma: Sandeep Wagle, APTART Technical Advisory Services

We have recommended Dishman Pharma at current levels. It has not moved up too much, it is just 3% up.

Sandeep Wagle, Founder & MD, APTART Technical Advisory Services, www.aptartindia.com (Technical Check), in a chat with ET Now, gives his call Dishman Pharma.

What is the call on Dishman Pharma?

We have recommended Dishman Pharma at current levels. It has not moved up too much, it is just 3% up and I see a move at the current level of 74-80, I see a move till 82-83, that is quite a big move.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Dishman Pharma: Sandeep Wagle, APTART Technical Advisory Services
Text Size:AAA
Success
This article has been saved

*

+